Cdh5em1Anpko
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Cdh5em1Anpko |
| Name: |
cadherin 5; endonuclease-mediated mutation 1, Andrew P Kowalczyk |
| MGI ID: |
MGI:8437132 |
| Synonyms: |
VE-cadDEE |
| Gene: |
Cdh5 Location: Chr8:104828257-104871143 bp, + strand Genetic Position: Chr8, 53.04 cM
|
| Alliance: |
Cdh5em1Anpko page
|
|
| Strain of Origin: |
Not Applicable
|
|
| Allele Type: |
|
Endonuclease-mediated (Not Applicable) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details:
Aspartic acid codon 646 (GAT) and glutamic acid codons 647 and 648 (GAG) were changed top alanine (GCA) (p.D646_E648delinsAAA) using an sgRNA and an ssODN template with CRISPR/Cas9 technology. The mutation disrupts binding of the encoded protein to the Ctnnd1 protein, which leads to microvascular patterning defects.
(J:291325)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Cdh5 Mutation: |
56 strains or lines available
|
|
| Original: |
J:291325 Grimsley-Myers CM, et al., VE-cadherin endocytosis controls vascular integrity and patterning during development. J Cell Biol. 2020 May 4;219(5) |
| All: |
1 reference(s) |
|